Daily non-political popular news in brief.
Tequila raw ingredient being developed into drug-carrier that targets colon diseases
03-27-2007 · EurekAlert!Compounds derived from the blue agave, a fruit used to make tequila, show promise as a natural, more effective way to deliver drugs to the colon than conventional drug-carriers, according to chemists at the University of Guadalajara in Mexico. The discovery could lead to improved treatments for a variety of colon diseases, including ulcerative colitis, irritable bowel and cancer, they say. The research will be presented in March at the American Chemical Society national meeting.
Read more »
Keywords: tequila, raw, ingredient, developed, drug-carrier, targets, colon, diseases, drug, carrier, target, disease
« Previous | Next »
Similar news on "Tequila raw ingredient being developed into drug-carrier that targets colon diseases":
- No carrier necessary: This drug delivers itself
03-14-2007 · EurekAlert!
The problem of efficiently delivering drugs, especially those that are hydrophobic or water-repellant, to tumors or other disease sites has long challenged scientists to develop innovative delivery systems that keep these drugs intact until reaching their targets. Now scientists in the University at Buffalo's Institute for Lasers, Photonics and Biophotonics and Roswell Park Cancer Institute have developed an innovative solution in which the delivery system is the drug itself.
Similar news · Read more »
- Protein's new role discovered in autoimmune disease
01-02-2008 · EurekAlert!
A chemical messenger has been shown to have a previously unknown major role in autoimmune diseases like arthritis and lupus. Investigators at the University of Alabama at Birmingham found interleukin 17 plays a major role on shaping B cells' ability to create more and more disease-causing antibodies, which may generate new ideas in the ongoing search for better drug targets.
Similar news · Read more »
- Gene expression profiling of dengue virus infection in cell lines and patients
11-06-2007 · EurekAlert!
Researchers at the Novartis Institute for Tropical Diseases and the Genome Institute of Singapore have identified new host genes associated with dengue virus infection, which may open new avenues to developing a drug to treat the disease. The results suggest that drugs that target the host pathways may prove effective against dengue.
Similar news · Read more »
- Enzyme structure reveals new drug targets for cancer and other diseases
02-14-2008 · EurekAlert!
Researchers now have a clearer understanding of how a key protein controls gene activity and how mutations in the protein may cause disease. The work could provide new avenues to design drugs aimed at cancer, diabetes, HIV, and heart disease.
Similar news · Read more »
- Jefferson scientists uncover key pathway, potential drug targets in autoinflammatory disease
11-12-2007 · EurekAlert!
Molecular biologists at Jefferson's Kimmel Cancer Center in Philadelphia have detailed the cascade of cellular events behind some potentially dangerous autoinflammatory diseases. In doing so, they not only have gained a greater understanding of the disease process, but have also identified new potential drug targets for diseases ranging from arthritis to cancer.
Similar news · Read more »
- A 'micro pharmacy' inside
02-11-2008 · Massachusetts Institute of Technology (MIT)
A new thin-film coating developed at MIT can deliver controlled drug doses to specific targets in the body following implantation, essentially serving as a "micro pharmacy." The film could eventually be used to deliver drugs for many diseases.
Similar news · Read more »
- UIC chemists characterize Alzheimer's neurotoxin structure
12-03-2007 · EurekAlert!
A team of UIC chemists has characterized the molecular structure of the intermediate stage of plaque-forming amyloid fibrils, believed to cause Alzheimer's disease. The finding may lead to new drug targets for this and other amyloid diseases, such as Parkinson's and Creutzfeldt-Jakob.
Similar news · Read more »
- MIT model could predict cells' response to drugs
07-30-2007 · EurekAlert!
MIT researchers have developed a model that could predict how cells will respond to targeted drug therapies. Models based on this approach could help doctors make better treatment choices and drug developers identify the ideal compound. In addition, the model could help test the effectiveness of drugs for a wide range of diseases, including cancer, arthirtis, and immune system disorders.
Similar news · Read more »
- Blueberries contain chemical that may help prevent colon cancer
03-25-2007 · EurekAlert!
A compound in blueberries shows promise of preventing colon cancer in animals, according to a joint study by scientists at Rutgers University and the US Department of Agriculture. The compound, pterostilbene, is a potent antioxidant that could be developed into a pill with the potential for fewer side effects than some commercial drugs that are currently used to prevent the disease. The study will be presented in March during the American Chemical Society national meeting.
Similar news · Read more »
- Molecular profiling can accurately predict survival in colon cancer patients
09-25-2007 · EurekAlert!
Researchers in the Netherlands have developed a method of accurately predicting which patients with colon cancer are most likely to have their disease recur after surgery and who would, therefore, be likely to benefit from additional chemotherapy. Professor Rob Tollenaar presented the findings at the European Cancer Conference in Barcelona today.
Similar news · Read more »
